{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:38:13Z","timestamp":1794461893287,"version":"4.9.1"},"reference-count":40,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["20250535"],"award-info":[{"award-number":["20250535"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"?Medicine + X? Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University","award":["2025JBGS08"],"award-info":[{"award-number":["2025JBGS08"]}]},{"name":"National Natural Science Foundation of China (NSFC)","award":["22367022"],"award-info":[{"award-number":["22367022"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Jilin Provincial Science and Technology Development Program","award":["202601ZYTS138"],"award-info":[{"award-number":["202601ZYTS138"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cisplatin (DDP) resistance remains a key factor contributing to the high mortality rate among ovarian cancer patients. The Pt(II)\u2212DNA covalent adduct is prone to removal through changes in gene expression in tumor cells, resulting in DDP resistance. To address this challenge, developing a non-metallic DNA intercalator is crucial. In this study, we incorporate the alkaloid aloperine (Alo) into a traditional RNA-binding agent, pyronine (PY), yielding a pyronine\u2212aloperine conjugate (PY\u2212Alo) as a nucleus-targeted DNA intercalator. In the PY\u2212Alo structure, the PY scaffold intercalates between DNA base pairs, and the bridged nitrogen atom in the Alo moiety forms an additional hydrogen bond with DNA bases. PY\u2212Alo can induce synergistic apoptosis and autophagy in A2780\/DDP cells. In vivo evaluations demonstrate that PY\u2212Alo significantly inhibits the progression of cisplatin-resistant ovarian cancer, with favorable biosafety. This study also illustrates a feasible strategy for converting a natural alkaloid into a DNA intercalator as a chemotherapeutic agent.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c00799","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:02:10Z","timestamp":1789149730000},"source":"Crossref","is-referenced-by-count":0,"title":["A Non-Metallic DNA Intercalator from Pyronine-Aloperine Conjugation Reverses Cisplatin Resistance in Ovarian Cancer"],"prefix":"10.1021","author":[{"given":"Ling-Li","family":"Wang","sequence":"first","affiliation":[{"name":"Jilin University , , ,","place":["Changchun, China, 130021"]},{"name":"Jilin University , , ,","place":["Changchun, China, 130021"]},{"name":"Yanbian University , , ,","place":["Yanji, China, 133002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Jilin University , , ,","place":["Changchun, China, 130012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Li","sequence":"additional","affiliation":[{"name":"Jilin University , , 1266 Fujin Road , ,","place":["Changchun, China, 130012"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-9846","authenticated-orcid":true,"given":"Jing-Yi","family":"Jin","sequence":"additional","affiliation":[{"name":"Yanbian University , , ,","place":["Yanji, China, 133002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jilin University , , ,","place":["Changchun, China, 130021"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jilin University , , ,","place":["Changchun, China, 130021"]},{"name":"Jilin University , , ,","place":["Changchun, China, 130021"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2026091114020072100_cit1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin."},{"key":"2026091114020072100_cit2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.phrs.2018.09.031","article-title":"PARP inhibition paltnum-based chemotherapy: chemopotentiation and neuroprotection","volume":"137","author":"McQuade","year":"2018","journal-title":"Pharmacol. Res."},{"key":"2026091114020072100_cit3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.phrs.2016.01.001","article-title":"Cisplatin resistance and opportunities for precision medicine","volume":"106","author":"Amable","year":"2016","journal-title":"Pharmalcol. Res."},{"key":"2026091114020072100_cit4","doi-asserted-by":"publisher","first-page":"114205","DOI":"10.1016\/j.ejmech.2022.114205","article-title":"Therapeutic strategies to overcome cisplatin resistance in ovarian cancer","volume":"232","author":"Song","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026091114020072100_cit5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/mc.22971","article-title":"Core fucosylation of copper transporter 1 plays a crucial role in cispslatin-resistance of epithelial ovarian cancer by regulating drug uptake","volume":"58","author":"Lv","year":"2019","journal-title":"Mol. Cancinog."},{"key":"2026091114020072100_cit6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/mc.20184","article-title":"Enhanced \u03b3-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity","volume":"45","author":"Das","year":"2006","journal-title":"Mol. Carcinog."},{"key":"2026091114020072100_cit7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12032-025-02812-3","article-title":"Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies","volume":"42","author":"Yusoh","year":"2025","journal-title":"Med. Oncol."},{"key":"2026091114020072100_cit8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"2026091114020072100_cit9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.advms.2025.01.005","article-title":"Novel factors of cisplatin resistance in epithelial ovarian tumours","volume":"70","author":"Harvanik","year":"2025","journal-title":"Adv. Med. Sci."},{"key":"2026091114020072100_cit10","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1039\/d5dt01704a","article-title":"Advances in nano-drug delivery systems for metallic compounds in cancer therapy: challenges and future perspectives","volume":"54","author":"Joseph","year":"2025","journal-title":"Dalton Trans."},{"key":"2026091114020072100_cit11","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1021\/acs.chemrev.5b00597","article-title":"The next generation of platinum drugs: targeted Pt(II) agents, nanoparticle delivery, and Pt(IV) prodrugs","volume":"116","author":"Johnstone","year":"2016","journal-title":"Chem. Rev."},{"key":"2026091114020072100_cit12","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202505930","article-title":"Evoking simultaneous ferroptosis and apoptosis by a dual-locked platinum(IV) prodrug for synergistic chemo-immunotherapy","volume":"64","author":"Meng","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"2026091114020072100_cit13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1021\/jacs.3c12706","article-title":"Nuclear-trageting lipid PtIV prodrug amphiphile cooperates with siRNA for enhanced cancer immunochemotherapy by amplifying Pt-DNA adducts and reducing phosphatidylserine exposure","volume":"146","author":"Wei","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"2026091114020072100_cit14","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1200\/jco.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"2026091114020072100_cit15","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ygyno.2004.08.028","article-title":"A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer","volume":"95","author":"Berkenblit","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"2026091114020072100_cit16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4137\/cmo.s38204","article-title":"Weekly paclitaxel versus three-weekly paclitaxel in recurrent platinum-resistant epithelial ovarian and peritoneal cancers: a phase III study","volume":"10","author":"Osamn","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"key":"2026091114020072100_cit17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/01443615.2017.1290056","article-title":"Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer","volume":"37","author":"Bozkaya","year":"2017","journal-title":"J. Obstet. Gynaecol."},{"key":"2026091114020072100_cit18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/mc.23590","article-title":"Baohuoside I inhibits reisistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-\u03b11\/ATG5 axis","volume":"62","author":"Zhou","year":"2023","journal-title":"Mol. Carcinog."},{"key":"2026091114020072100_cit19","doi-asserted-by":"publisher","first-page":"112801","DOI":"10.1016\/j.isci.2025.112801","article-title":"Erythrabyssin II is identified as a late-stage autophagy inhibitor reversing chemoresistance and promoting apoptosis in ovarian cancer","volume":"28","author":"Mo","year":"2025","journal-title":"iScience"},{"key":"2026091114020072100_cit20","doi-asserted-by":"publisher","first-page":"538137","DOI":"10.3389\/fphar.2020.538137","article-title":"A review on recent advances in aloperine research: pharmacological activities and underlying biological mechanisms","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"2026091114020072100_cit21","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.3390\/ijms25179226","article-title":"Discovery of aloperine as a potential antineoplasticagent for cholangiocarcinoma harboring mutant IDH1","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026091114020072100_cit22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/1389557521666210831155426","article-title":"Research progress on the natural product aloperine and its derivatives","volume":"22","author":"Cheng","year":"2022","journal-title":"Mini-Rev. Med. Chem."},{"key":"2026091114020072100_cit23","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/10286020.2024.2349660","article-title":"Design, synthesis and biological evaluation of aloperine derivatives as potential anticancer agents","volume":"26","author":"Zhao","year":"2024","journal-title":"J. Asian Nat. Prod. Res."},{"key":"2026091114020072100_cit24","doi-asserted-by":"publisher","first-page":"2308307","DOI":"10.1002\/advs.202308307","article-title":"Aloperine suppresses cancer progression by interacting with VPS4A to inhibit autophagosome-lysosome fusion in NSCLC","volume":"11","author":"Guo","year":"2024","journal-title":"Adv. Sci."},{"key":"2026091114020072100_cit25","first-page":"5760","article-title":"Cytostatic and cytotoxic properties of pyronin: relation to mitochondrial localization of the dye and its interaction with RNA","volume":"46","author":"Darzynkiewicz","year":"1986","journal-title":"Cancer Res."},{"key":"2026091114020072100_cit26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1039\/d0nj04808a","article-title":"Facile synthesis of pyronine-9-thione via a trisulfur radical anion mechanism","volume":"45","author":"Mai","year":"2021","journal-title":"New J. Chem."},{"key":"2026091114020072100_cit27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.devcel.2024.01.003","article-title":"A single fluorescent probe to examine the dynamics of mitochondria-lysosome interplay and extracellular vesicle role in ferroptosis","volume":"59","author":"Wang","year":"2024","journal-title":"Dev. Cell"},{"key":"2026091114020072100_cit28","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s40843-025-3447-4","article-title":"Repurposing antihistamine to chemotherapy via a molecular delivery platform co-targeting mitochondria and endoplasmic reticulum","volume":"68","author":"Wang","year":"2025","journal-title":"Sci. China Mater."},{"key":"2026091114020072100_cit29","doi-asserted-by":"publisher","first-page":"143104","DOI":"10.1016\/j.cej.2023.143104","article-title":"A single fluorescent probe reveals changes in endoplasmic reticulum-mitochondria contact in hepatocytes during ferroptosis","volume":"466","author":"Wang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"2026091114020072100_cit30","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/nar\/16.6.2671","article-title":"The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG)","volume":"16","author":"Teng","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"2026091114020072100_cit31","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1039\/d0sc02889d","article-title":"A ratiometric fluorescent probe for real-time monitoring of intracellular glutathione fluctuations in response to cisplatin","volume":"11","author":"Liu","year":"2020","journal-title":"Chem. Sci."},{"key":"2026091114020072100_cit32","doi-asserted-by":"publisher","first-page":"620501","DOI":"10.3389\/ftox.2021.620501","article-title":"Multi-spectroscopic and molecular simulation approaches to characterize the intercalation binding of 1-naphthaleneacetic acid with calf thymus DNA","volume":"3","author":"Hu","year":"2021","journal-title":"Front. Toxicol."},{"key":"2026091114020072100_cit33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0022-1759(74)90010-6","article-title":"Detection of anti-DNA antibodies by counterimmunoelectrophoresis","volume":"5","author":"Arquembourg","year":"1974","journal-title":"J. Immunol. Methods"},{"key":"2026091114020072100_cit34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/cyto.990080205","article-title":"Interactions of pyronine Y(G) with nucleic acids","volume":"8","author":"Kapuscinski","year":"1987","journal-title":"Cytometry"},{"key":"2026091114020072100_cit35","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.2147\/OTT.S165262","article-title":"Aloperine executes antitumor effects through the induction of apoptosis and cell cycle arrest in prostate cancer in vitro and in vivo","volume":"11","author":"Ling","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2026091114020072100_cit36","doi-asserted-by":"publisher","first-page":"155876","DOI":"10.1016\/j.phymed.2024.155876","article-title":"Daphnetin induces ferroptosis in ovarian cancer by inhibiting NAD(P)H: Quinone oxidoreductase 1 (NQO1)","volume":"132","author":"Ma","year":"2024","journal-title":"Phytomedicine"},{"key":"2026091114020072100_cit37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12917-026-05337-7","article-title":"Aloperine alleviates LPS-induced inflammation in bovine intestinal epithelial cells through autophagy and TLR\/p38 MAPK\/NF-\u03baB pathway","volume":"22","author":"Tan","year":"2026","journal-title":"BMC Vet. Res."},{"key":"2026091114020072100_cit38","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.2147\/DDDT.S126464","article-title":"Cisplatin induces protective autophagy through activation of BECN in human bladder cancer cells","volume":"16","author":"Lin","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"2026091114020072100_cit39","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kra\u0308mer","year":"2014","journal-title":"Bioinformatics"},{"key":"2026091114020072100_cit40","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.bbadis.2009.04.003","article-title":"OXPHOS gene expression and control in mitochondrial disorders","volume":"1792","author":"Reinecke","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c00799","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/doi\/10.1021\/acs.jmedchem.6c00799\/68488682\/jm6c00799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/doi\/10.1021\/acs.jmedchem.6c00799\/68488682\/jm6c00799.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:21:33Z","timestamp":1794457293000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/doi\/10.1021\/acs.jmedchem.6c00799\/5428697\/A-Non-Metallic-DNA-Intercalator-from-Pyronine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c00799","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c00799.s003","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}